Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
Posted on: Tuesday, 6 January 2009, 08:30 CST
The report projects a 12-month target price of
The research report also provides a thorough peer group comparison with valuation analyses, views and opinions on AMDL's projected financial performance for the 2009 fiscal year, and historical financials.
According to Mr. Rudd, "AMDL has taken major initiatives to build its strengths while reorganizing top management and still producing respectable financials which has resulted in AMDL being one of the most under priced stocks we have seen in a long time."
A full copy of the report is available for downloading online at
http://www.ruddreport.com or by contacting Ms.
About AMDL:
Headquartered in
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
AMDL Contact: Kristine Szarkowitz Director-Investor Relations kszarkowitz@amdl.com (Tel :) 206.310.5323SOURCE AMDL, Inc.
Source: PR Newswire
Related Articles
- China Aoxing Pharmaceutical Company to Present at 2009 China Growth Conference of Adam Friedman Associates on October 28, 2009
- China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results
- China Aoxing Pharmaceutical Company to Present at 2009 Roth China Conference
- China Aoxing Pharmaceutical Company to Present at Maxim Group Third Annual Growth Conference
- China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2009
- China Aoxing Pharmaceutical Honored to Co-Sponsor the 10th National Conference on Drug Dependence and Sino-US Symposium in Drug Abuse and HIV/HCV Co-Morbidity
- China Shenghuo Pharmaceutical Holdings, Inc. To Present at Roth 2007 New York Conference
- China Organic Reports Record Financial Performance for Q2 2007
- China Shenghuo Pharmaceutical Holdings, Inc. To Ring Opening Bell at American Stock Exchange
- Aida Pharmaceuticals Retains Equity Performance Group for Investor Relations
 |
 |
User Comments (0)
RSS Feeds